glp 1 medical therapy marietta Weight Loss in GA Medical Weight Loss In Marietta,

[PMID: 2742603] PubMed record related to this compound for laboratory literature review

Image Credit: azimmytws / Shutterstock.com A recent BMJ study determines whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists by type 2 diabetes (T2D) patients increases the risk of self-harm, suicidal ideation, and suicide as compared to patients prescribed dipeptidyl peptidase-4 (DPP-4) or sodium-glucose cotransporter-2 (SGLT-2) inhibitors

Description Peptide Research Additional information Storage & Handling FAQ For Research Use Only

While assessing BMI is an important first step, treatment decisions always involve thorough discussions with each patient to ensure that recommended therapies align with their unique health needs, goals, and preferences

Published today in Frontline Gastroenterology, this review on behalf of the Roux Group / AUGIS takes a practical look at this fast-evolving space